UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 259

Sortiert nach

Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone

Journal of substance abuse treatment, 2018-02, Vol.85, p.49-55

2018

Volltextzugriff (PDF)

State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995–2017: A difference-in-differences analysis

PLoS medicine, 2020-09, Vol.17 (9), p.e1003272-e1003272

2020

Volltextzugriff (PDF)

Opioid Use Disorders

Child and adolescent psychiatric clinics of North America, 2016-07, Vol.25 (3), p.473-487

2016

Volltextzugriff (PDF)

Characteristics of mHealth therapy app engagement by young adults with OUD

Journal of addictive diseases, 2024-06, p.1-6

2024

Volltextzugriff (PDF)

Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth

Journal of the American Academy of Child and Adolescent Psychiatry, 2011-11, Vol.50 (11), p.1120-1128

2011

Volltextzugriff (PDF)

Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case‐series and feasibility

Addiction (Abingdon, England), 2010-09, Vol.105 (9), p.1669-1676

2010

Volltextzugriff (PDF)

Working memory predicts outcome for youth opioid addiction treatment

Drug and alcohol dependence, 2015-11, Vol.156, p.e232-e232

2015

Volltextzugriff (PDF)

Extended-release buprenorphine induction in opioid non-tolerant incarcerated individuals

Drug and alcohol dependence reports, 2024-09, Vol.12, p.100261, Article 100261

2024

Volltextzugriff (PDF)

Comparing outcomes of extended-release naltrexone in adolescents and young adults with opioid use disorder

Journal of substance use and addiction treatment, 2024-08, Vol.163, p.209162, Article 209162

2024

Volltextzugriff (PDF)

Interpretation of surrogate endpoints in the era of the 21st Century Cures Act

BMJ (Online), 2016-12, Vol.355, p.i6286

2016

Volltextzugriff (PDF)

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy‐Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

The oncologist (Dayton, Ohio), 2021-08, Vol.26 (8), p.e1418-e1426

2021

Volltextzugriff (PDF)

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

Contemporary clinical trials, 2016-09, Vol.50, p.253-264

2016

Volltextzugriff (PDF)

Health care use and cost of treatment for adolescents and young adults with opioid use disorder

Journal of substance use and addiction treatment, 2023-11, Vol.154, p.209137-209137, Article 209137

2023

Volltextzugriff (PDF)

Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders

Drug and alcohol dependence, 2009-01, Vol.99 (1), p.141-149

2009

Volltextzugriff (PDF)

Working Memory Training for Adolescents with Cannabis Use Disorders: A Randomized Controlled Trial

Journal of child & adolescent substance abuse, 2018-01, Vol.27 (4), p.211-226

2018

Volltextzugriff (PDF)

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Drug and alcohol dependence reports, 2022-12, Vol.5, p.100100, Article 100100

2022

Volltextzugriff (PDF)

Interactions between Emotion Regulation and Trait Mindfulness on Onset of Opioid Use and Progression to Injection Drug Use for Youth With Opioid Use Disorders

Journal of adolescent health, 2016-02, Vol.58 (2), p.S109-S109

2016

Volltextzugriff (PDF)

Initial Feasibility and Validity of a Prospective Memory Training Program in a Substance Use Treatment Population

Experimental and clinical psychopharmacology, 2016-10, Vol.24 (5), p.390-399

2016

Volltextzugriff (PDF)

A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder

Addiction (Abingdon, England), 2021-03, Vol.116 (3), p.548-557

2021

Volltextzugriff (PDF)

Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone

Addiction (Abingdon, England), 2008-08, Vol.103 (8), p.1399-1401

Fishman, Marc

2008

Volltextzugriff (PDF)

Baseline Depressive Symptoms Predict Poor Substance Use Outcome Following Adolescent Residential Treatment

Journal of the American Academy of Child and Adolescent Psychiatry, 2007-08, Vol.46 (8), p.1062-1069

2007

Volltextzugriff (PDF)

Adolescent Substance Abuse and Mental Health: Problem Co-Occurrence and Access to Services

Journal of child & adolescent substance abuse, 2012-09, Vol.21 (4), p.310-322

2012

Volltextzugriff (PDF)

Buprenorphine for Prescription Opioid Addiction in a Patient With Depression and Alcohol Dependence

The American journal of psychiatry, 2011-07, Vol.168 (7), p.675-679

2011

Volltextzugriff (PDF)

Treatment of opioid-dependent adolescents and young adults with buprenorphine

Current psychiatry reports, 2009-10, Vol.11 (5), p.360-363

2009

Volltextzugriff (PDF)

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(222)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(148)
Life Sciences & Biomedicine
(123)
Humans
(106)
Male
(54)
Female
(53)
Substance Abuse
(49)
Adolescent
(37)
Social Sciences
(35)
Adult
(33)
Biological And Medical Sciences
(32)
Narcotics
(31)
Psychology
(30)
Psychiatry
(29)
Opioid-Related Disorders - Drug Therapy
(28)
Medical Sciences
(27)
Opioid Use Disorder
(27)
Opioids
(27)
Substance Abuse Treatment
(27)
Naltrexone
(23)
Substance Use Disorder
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Relapse to opioid use disorder after inpatient treatment: Protective effect of injection naltrexone

State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995–2017: A difference-in-differences analysis

Opioid Use Disorders

Characteristics of mHealth therapy app engagement by young adults with OUD

Predictors of Abstinence: National Institute of Drug Abuse Multisite Buprenorphine/Naloxone Treatment Trial in Opioid-Dependent Youth

Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case‐series and feasibility

Working memory predicts outcome for youth opioid addiction treatment

Extended-release buprenorphine induction in opioid non-tolerant incarcerated individuals

Comparing outcomes of extended-release naltrexone in adolescents and young adults with opioid use disorder

Interpretation of surrogate endpoints in the era of the 21st Century Cures Act

The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy‐Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale

Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth

Health care use and cost of treatment for adolescents and young adults with opioid use disorder

Clinical characteristics of treatment-seeking adolescents with opioid versus cannabis/alcohol use disorders

Working Memory Training for Adolescents with Cannabis Use Disorders: A Randomized Controlled Trial

Time-lagged association between counseling and/or 12-Step attendance with subsequent opioid use in a secondary analysis from a randomized, clinical trial of medications for opioid use disorder

Interactions between Emotion Regulation and Trait Mindfulness on Onset of Opioid Use and Progression to Injection Drug Use for Youth With Opioid Use Disorders

Initial Feasibility and Validity of a Prospective Memory Training Program in a Substance Use Treatment Population

A pilot randomized controlled trial of assertive treatment including family involvement and home delivery of medication for young adults with opioid use disorder

Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone

Baseline Depressive Symptoms Predict Poor Substance Use Outcome Following Adolescent Residential Treatment

Adolescent Substance Abuse and Mental Health: Problem Co-Occurrence and Access to Services

Buprenorphine for Prescription Opioid Addiction in a Patient With Depression and Alcohol Dependence

Treatment of opioid-dependent adolescents and young adults with buprenorphine

Suchergebnisse filtern